BioPharma

13 July, 2026 | Monday | News

Takeda Backs Indonesia's Plasma Ambitions with US$30 Million Investment to Build ASEAN's First Integrated Plasma Ecosystem

Ministry of Health of the Republic of Indonesia Grants Plasma Fractionation License, Enabling Takeda to Collect and Fractionate Plasma as Part of Multi-Phased Initiative Takeda Will Initially Invest up to ...

Lab

01 July, 2026 | Wednesday | News

Colossal Foundation and University of Tasmania Partner to Fight Deadly Tasmanian Devil Cancer with Gene Editing and Vaccines

The collaboration leverages Colossal's marsupial de-extinction and conservation biotechnology platform to save the Tasmanian devil from a contagious cancer that has driven 80% population declines across Tasmani...

BioTech

08 July, 2026 | Wednesday | Analysis

After the Rush: APAC's mRNA and Vaccine Capacity Hangover

In June 2022,  South Korea had something it had wanted for two years: a COVID-19 vaccine of its own. SKYCovione, developed by SK bioscience with the University of Washington's Institute for Protein Design ...

Contract Services

13 July, 2026 | Monday | Analysis

Can APAC Biomanufacturing Decarbonise Without Pricing Itself Out?

Scope 3 clauses, single-use plastic, water and energy intensity: the “green premium” has become the defining question for the CDMOs that built Asia’s manufacturing franchise on price. Is it an...

Consumer Health

02 July, 2026 | Thursday | News

ALR Technologies Expands Diabetes Device Business with CGM Medical Acquisition

ALR Technologies SG Ltd ("ALRT" or the "Company") (OTC: ALRTF), the diabetes management company, announces it has entered into a Letter of Intent ("LOI") to acquire 100% equity of CGM Medical Technology Singapo...

Medtech

10 July, 2026 | Friday | News

India's Garware Fulflex Acquires U.S. Medical Manufacturing Facility to Accelerate Global Expansion

Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facility in Jacksonville, Texas, marking a major milestone i...

Cell & Gene

08 July, 2026 | Wednesday | News

World's First International Patient Begins Satri-cel Treatment at Jiahui International Cancer Center

Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic m...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close